Three firms, two training programs garner Greater Baltimore Committee’s 2009 Bioscience Awards

square-homepage1

(left to right) Osiris Therapeutics, Inc. and Frank Howard, PhRMAMaryland biotech CEOs and companies were honored today by the Greater Baltimore Committee as winners of the region’s fourth bioscience award competition.

Winners of the 2009 Bioscience Awards are:

  • Best New Product or Progress: C. Randal Mills, Ph.D., president and CEO, Osiris Therapeutics, Inc. Mills’ Columbia-based company has spent more than $300 million developing stem cell therapies. The funding has allowed Osiris to complete clinical trials necessary to demonstrate the safety and efficacy of two next-generation stem cell treatments for serious conditions such as graft versus host disease, Crohn’s disease, arthritis, diabetes, (left to right) Karen Olsen, BioMarker Strategies and Mark Rapson, Katz Aboschpulmonary disease and heart attacks.
  • Leadership in Bioscience Award: Kären Olsen, CEO, BioMarker Strategies, LLC. Olsen’s tissue-based cancer diagnostics company is based at the Science + Technology Park at Johns Hopkins. BioMarker Strategies is developing live cell biomarker tests for solid-tumor based cancers.
  • Entrepreneurial Spirit Award: Suzanne Sysko Clough, M.D., founder and chief medical officer, WellDoc Communications, Inc. Clough’s Baltimore-based health care company develops technology-based solutions to improve diabetes outcomes and reduce health care costs. Since founded, WellDoc successfully raised more than $6 million in angel funding and is moving forward with a 300 patient trial sponsored by leaders in telecommunications, medical device, and health insurance provider industries.
  • President’s Award:
    (left to right) Suzanne Sysko Clough, WellDoc Communications and Howard Schwartz, DLA Piper
    • Ellen Hemmerly, executive director, bwtech@UMBC Research & Technology Park, co-principal investigator for NSF Grant, coordinator of incubation operations for ACTiVATE and ACTiVATE Leadership Team. ACTiVATE® is a year-long
      program to train women with significant technical or business experience to be entrepreneurs and to create start-up companies from inventions from Maryland research institutions and federal agencies.
    • Kathleen O’Donnell Weiss, executive director, The BioTechnical Institute of Maryland, Inc. (BTI). Located in Baltimore, BTI fills a need for specialty scientific training of entry-level biotechnicians for employment in Maryland’s rapidly expanding biotechnology industry.

 

Nurturing development of the region’s bioscience industr(left to right) Ellen Hemmerly, ACTiVATE, Kathleen O'Donnell Weiss, BTI, and Liz Pettengill, GBCy is a top priority of the GBC, the region’s most prominent organization of business and civic leaders.

Winners of the 2009 Bioscience Awards were selected by a panel of judges from among 18 nominees submitted by businesses, bioscience advocates, higher education institutions and government agencies.

Judges for this year’s awards were: Scott Allocco, president, BioMarker Strategies; Judith Britz, Ph.D., principal, Britz Consulting; David J. Fink, Ph.D., biotech entrepreneur-in-residence, techcenter@UMBC; Elizabeth Good Mazhari, director, Strategic Investments, University of Maryland, Baltimore; Mark E. Rapson, CPA, shareholder, Board of Directors, Katz Abosch; Howard S. Schwartz, Esq., partner, DLA Piper; and Paul Silber, Ph.D., biotechnology investor.

Program sponsor for the event is DLA Piper. Patron sponsors are Katz Abosch and PhRMA. Media sponsors are the Daily Record and the Gazette of Politics and Business.

Comments are closed.